Psychiatry and Neurology, Neurology · Brandon, FL
NPI
1669449963
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
401 N Parson Ave, # 105
Brandon, FL, 33510
Phone (813) 653-2775
Groups this clinician bills Medicare through
Medicare paid, 2024
$234K
3,103 services
Medicare patients, 2024
730
Average age 76
Drug cost, 2024
$3.9M
6,878 prescriptions
Company payments, 2025
$2,502
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rafael M Rodriguez was code 99232 (hospital e&m - subsequent), 2,000 times for 336 patients. In total Rafael M Rodriguez billed 3,103 services in 21 codes, and Medicare paid $234K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 2,000 | 336 | $60.98 | $122K |
| 99214 Office E&M - Established | Office | 478 | 278 | $83.21 | $40K |
| 99223 Hospital E&M - Initial | Facility | 231 | 220 | $134.72 | $31K |
| 95819 Neurologic | Facility | 107 | 104 | $43.15 | $4,617 |
| 99204 Office E&M - New | Office | 65 | 65 | $94.15 | $6,120 |
| 95816 Neurologic | Office | 45 | 45 | $285.87 | $13K |
| 99213 Office E&M - Established | Office | 42 | 29 | $51.09 | $2,146 |
| 99205 Office E&M - New | Office | 39 | 39 | $140.68 | $5,486 |
| 95886 Electrical Nerve Conductivity | Office | 39 | 20 | $65.32 | $2,547 |
| 95909 Electrical Nerve Conductivity | Office | 14 | 14 | $79.85 | $1,118 |
| 99215 Office E&M - Established | Office | 12 | 12 | $137.68 | $1,652 |
By year: 2022 $199K for 2,457 services; 2023 $207K for 2,569 services; 2024 $234K for 3,103 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rafael M Rodriguez prescribed most often to Medicare patients was Donepezil Hcl, with 642 prescriptions and refills. In total Rafael M Rodriguez wrote 6,878 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 642 | 1,432 | 205 | $5,756 |
| Memantine Hcl Generic | 593 | 1,363 | 201 | $18K |
| Gabapentin Generic | 572 | 1,301 | 197 | $12K |
| Levetiracetam Generic | 394 | 860 | 97 | $12K |
| Primidone Generic | 307 | 657 | 81 | $6,065 |
| Baclofen Generic | 267 | 561 | 91 | $3,242 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 256 | 641 | 95 | $4,090 |
| Duloxetine Hcl Generic | 239 | 529 | 76 | $6,100 |
| Lamotrigine Generic | 180 | 386 | 51 | $3,180 |
| Clopidogrel Clopidogrel Bisulfate | 153 | 408 | 60 | $1,727 |
| Topiramate Generic | 137 | 303 | 46 | $1,427 |
| Rasagiline Mesylate Generic | 121 | 276 | 35 | $22K |
| Quetiapine Fumarate Generic | 120 | 246 | 38 | $3,462 |
| Meloxicam Generic | 115 | 177 | 31 | $708 |
| Clonazepam Generic | 113 | 198 | 33 | $1,337 |
Brand drugs: 568 claims; generic drugs: 6,271 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rafael M Rodriguez $2,502 ($2,502 in general payments such as food, travel and fees) from 29 companies. The largest payer was Pfizer Inc. with $172.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 10 | $172 |
| Neurocrine BioSciences, Inc. NBIX | 8 | $168 |
| Abbvie Inc. ABBV | 12 | $165 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 9 | $164 |
| Janssen Biotech, Inc. JNJ | 5 | $162 |
| Eisai Inc. 4523.T | 9 | $147 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $136 |
| Argenx US, Inc. ARGX | 5 | $126 |
| UCB, Inc. UCB.BR | 5 | $126 |
| Teva Pharmaceuticals USA, Inc. TEVA | 6 | $113 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.